FDA obesity public meeting
This article was originally published in The Tan Sheet
Executive Summary
The agency will discuss the available evidence that it "can look to in order to guide rational, effective public efforts to prevent and treat obesity by behavioral or medical interventions, or combinations of both" at an upcoming open meeting, according to an Oct. 7 1notice. The meeting, which is being organized by FDA's Obesity Working Group, will be held Oct. 23 at NIH in Bethesda, Md. Commissioner Mark McClellan, MD/PhD, has frequently talked about the need for more anti-obesity medications...